| 1 |
35487360 | Critical target identification and human health risk ranking of metal ions based on mechanism-driven modeling. | 2022 Aug |
1 |
| 2 |
34502536 | Fe-N Co-Doped Titanium Dioxide Nanoparticles Induce Cell Death in Human Lung Fibroblasts in a p53-Independent Manner. | 2021 Sep 6 |
2 |
| 3 |
31112603 | Induction of Senescence in Cancer Cells by a Novel Combination of Cucurbitacin B and Withanone: Molecular Mechanism and Therapeutic Potential. | 2020 May 22 |
1 |
| 4 |
31953488 | Liquid-like droplet formation by tumor suppressor p53 induced by multivalent electrostatic interactions between two disordered domains. | 2020 Jan 17 |
1 |
| 5 |
32032660 | Synergistic activation of p53 by actinomycin D and nutlin-3a is associated with the upregulation of crucial regulators and effectors of innate immunity. | 2020 May |
2 |
| 6 |
32318262 | Integrated analysis of transcriptomic and metabolomic profiling reveal the p53 associated pathways underlying the response to ionizing radiation in HBE cells. | 2020 |
1 |
| 7 |
31519237 | Ratiometric fluorescence strategy for p53 gene assay by using nitrogen doped graphene quantum dots and berberine as fluorescence reporters. | 2019 Nov 25 |
2 |
| 8 |
31638225 | SSTR5‑AS1 functions as a ceRNA to regulate CA2 by sponging miR‑15b‑5p for the development and prognosis of HBV‑related hepatocellular carcinoma. | 2019 Dec |
1 |
| 9 |
31652301 | Allosteric changes in HDM2 by the ATM phosphomimetic S395D mutation: implications on HDM2 function. | 2019 Nov 15 |
1 |
| 10 |
26982372 | Bcl-2/MDM2 Dual Inhibitors Based on Universal Pyramid-Like α-Helical Mimetics. | 2016 Apr 14 |
1 |
| 11 |
19242108 | Downregulation of Wip-1 phosphatase expression in MCF-7 breast cancer cells enhances doxorubicin-induced apoptosis through p53-mediated transcriptional activation of Bax. | 2009 Mar 15 |
1 |
| 12 |
19248770 | Enhancing activity of N-glycosylation for constitutive proteins secretions in non-polarized cells. | 2009 Apr 17 |
2 |
| 13 |
17582597 | Cross-talks between cyclooxygenase-2 and tumor suppressor protein p53: Balancing life and death during inflammatory stress and carcinogenesis. | 2007 Sep 1 |
1 |
| 14 |
14965371 | p53-independent anti-tumor effects of the nitrogen-containing bisphosphonate zoledronic acid. | 2004 Feb |
1 |
| 15 |
15308759 | p53 elevation in relation to levels and cytotoxicity of mono- and bifunctional melphalan-DNA adducts. | 2004 Nov |
1 |
| 16 |
15665582 | The potential roles of p53 tumor suppressor in nucleotide excision repair (NER) and base excision repair (BER). | 2004 Dec 31 |
1 |
| 17 |
12036943 | Induction of gene amplification as a gain-of-function phenotype of mutant p53 proteins. | 2002 Jun 1 |
1 |
| 18 |
12058967 | Sensitivity of p53-deficient cells to oxaliplatin and thio-TEPA (N, N', N" triethylenethiophosphoramide). | 2002 Apr |
1 |
| 19 |
12505283 | Molecular pathogenesis of human hepatocellular carcinoma. | 2002 Dec 27 |
1 |
| 20 |
11720736 | Tumor suppressor genes: at the crossroads of molecular carcinogenesis, molecular epidemiology and human risk assessment. | 2001 Dec |
1 |
| 21 |
11050162 | Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases. | 2000 Nov 7 |
1 |
| 22 |
11133809 | Differential gene expression in p53-mediated G(1) arrest of human fibroblasts after gamma-irradiation or N-phosphoacetyl-L-aspartate treatment. | 2000 Dec |
1 |
| 23 |
9459175 | Relationship between nitrogen mustard drug resistance in B-cell chronic lymphocytic leukemia (B-CLL) and protein expression of Bcl-2, Bax, Bcl-X and p53. | 1997 Dec 16 |
1 |
| 24 |
9816057 | Induction of apoptosis and cell cycle-specific change in expression of p53 in normal lymphocytes and MOLT-4 leukemic cells by nitrogen mustard. | 1995 Aug |
4 |
| 25 |
7954409 | p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. | 1994 Nov 15 |
1 |